Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Biontech Se (BNTX)

278 + Investors. Track Smart Money conviction in BNTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +12
Streak
1Q ▲
Buyers last Q
55%

Smart Money Signals — BNTX

Based on 284 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added BNTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 94% of 3.0Y peak

94% of all-time peak
284 funds currently hold this stock — 94% of the 3.0-year high of 303 funds (reached 2024 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +7% more funds vs a year ago

fund count last 6Q
+19 new funds entered over the past year (+7% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 55% buying

144 buying118 selling
Last quarter: 144 funds bought or added vs 118 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~48 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 32 → 65 → 43 → 48. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

57% of holders stayed for 2+ years

■ 57% conviction (2yr+) ■ 23% medium ■ 20% new
162 out of 284 hedge funds have held BNTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~48 new funds/quarter

36 → 32 → 65 → 43 → 48 new funds/Q
New funds entering each quarter: 32 → 65 → 43 → 48. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 66% veterans vs 20% newcomers

■ 66% veterans ■ 14% 1-2yr ■ 20% new
Entry-cohort mix of 315 holders: 209 (66%) are 2+ year veterans, 44 entered 1–2 years ago, and 62 (20%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 63% AUM from top-100 funds

63% from top-100 AUM funds
51 of 280 holders are among the 100 largest funds by AUM, controlling 63% of total institutional value in BNTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.3
out of 10
Low Exit Risk
Exit risk score 3.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — BNTX

In 2026 Q2, 144 hedge funds were net buyers of BNTX (48 opened a new position, 96 added to an existing one), while 118 reduced or exited (82 trimmed, 36 sold completely) — a 55% buyer ratio, indicating a slight buying edge. 63% of total institutional value in BNTX is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +12 funds (more new holders than closures). Total institutional holders: 284.

Hedge Fund Ownership: BNTX

How many hedge funds hold BNTX — quarterly history vs. share price
Quarterly hedge fund ownership of BNTX vs. share price

Market Analysis: BNTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: BNTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Biontech Se (BNTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much BNTX has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 80d ago
BNTX
+3.9%
XLV
+6.4%

BNTX outperformed XLV by -2.5% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 35d ago
BNTX
+3.8%
XLV
+0.9%

Since the filing became public, BNTX outperformed XLV by +2.9% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

14 top-rated funds 5 high-conviction
Consensus
5.1
/ 10
breadth
×
Elite
3.9
/ 10
conviction
Hedge Fund Positioning: BNTX
278 + Investors

Track Smart Money conviction in BNTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 278 272 2.21%
13F Shares 50M 50M -0.53%
Total Value $4.30B $3.82B 12.69%
New Positions 48 43 +5
Increased Positions 90 92 -2
Closed Positions 38 54 -16
Reduced Positions 73 72 +1
Total Calls 18 13 38.46%
Total Puts 16 17 -5.88%
PUT/CALL Ratio 0.89 1.31 Neutral

Statistics: BNTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

278 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BNTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 BNTX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 GSK plc 13.75% 889,824 $82.8M
2 Davern Capital Partners, LP 11.97% 754,550 $70.2M
3 Logos Global Management LP 4.07% 1,015,000 $94.4M
4 Sectoral Asset Management Inc 2.72% 41,869 $3.9M
5 Tang Capital Management LLC 1.99% 470,000 $43.7M
6 Patient Square Capital LP 1.94% 134,429 $12.5M
7 Crocodile Capital Partners GmbH 1.87% 29,586 $2.8M
8 Long Focus Capital Management, LLC 1.48% 624,000 $58.1M
9 Diadema Partners LP 1.18% 100,000 $9.3M
10 CenterBook Partners LP 1.15% 251,083 $23.4M
11 Flossbach von Storch Se 0.94% 2,226,138 $207.1M
12 Baader Bank Aktiengesellschaft 0.84% 119,411 $11.1M
13 Keystone Investors Pte Ltd 0.76% 153,466 $14.3M
14 Quinn Opportunity Partners LLC 0.66% 153,832 $14.3M
15 Systrade AG 0.58% 10,000 $930K
16 Slow Capital, Inc. 0.54% 49,696 $4.6M
17 Privium Fund Management B.V. 0.51% 30,100 $2.8M
18 AlphaCentric Advisors LLC 0.49% 6,266 $583K
19 Temasek Holdings (Private) Ltd 0.38% 1,506,027 $140.1M
20 Lbp AM SA 0.36% 388,498 $36.1M
21 Virtus Investment Advisers, LLC 0.28% 12,844 $1.2M
22 Headlands Technologies LLC 0.27% 27,087 $2.5M
23 Palo Alto Investors LP 0.25% 19,614 $1.8M
24 Sankala Group LLC 0.25% 4,017 $373K
25 Arlington Capital Management, Inc. 0.24% 4,200 $391K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Biontech Se (BNTX)

What does the Smart Money Trend signal show for BNTX?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added BNTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for BNTX?

Slight buying edge — 55% buying: Last quarter: 144 funds bought or added vs 118 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for BNTX holders?

Elite ownership — 63% AUM from top-100 funds: 51 of 280 holders are among the 100 largest funds by AUM, controlling 63% of total institutional value in BNTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held BNTX?

57% of holders stayed for 2+ years: 162 out of 284 hedge funds have held BNTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Biontech Se (BNTX) following the 2026 Q2 hedge fund 13F filings?

As of today, BNTX has moved +3.8% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.9% for the XLV sector ETF — an outperformance of +2.9%. Since the quarter end (June 30, 2026), BNTX has gained +3.9% vs +6.4% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →